research reports and media, page-3738

What are the chances of a piggyback? Slim to none?

Not impossible but it would be fairly futile in my non legal backed opinion...
Our patent covers all the salts and variations and even the admin routes themselves:

"Preferably, the inhibiting or reducing, or treating is by administering an injection by the intra-muscular (IM) or sub-cutaneous (SC) routes, an intraventricular route, intracisternal route or intrathecal route, intra-venously (IV), intra-articularly (IA), peri-articularly, topically, via suppositories or orally." ¹


There are a number of research groups that are looking at it but I believe these aren't for commercial reasons. Not saying that no one on earth will try eventually once we blaze a paythway....but possibly aided with a big partner and Billions behind us, it wont be an easy route...for them!

Where would they source from? Bene wouldn't allow the commercial supply. Close to impossible to get a bio-similar...and even if they crack that, they need to license it, that would take years of clinical trials...and then we talk patent infringement after all that.

The oral version as you say doesn't have the bio-availability thus while it may show some basic efficacies in pain reductions and the rest, it doesn't come close to what our data is showing us.


My thoughts




REF
1) https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2020073089&tab=PCTDESCRIPTION